Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eriko Ogura
Development of Tumor-Induced Osteomalacia in a Subcutaneous Tumor, Defined by Venous Blood Sampling of Fibroblast Growth Factor-23
Internal Medicine
Internal Medicine
Medicine
Related publications
Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt
Journal of Investigative Medicine High Impact Case Reports
Risk
Epidemiology
Reliability
Safety
Safety Research
Quality
Tumor-Induced Osteomalacia
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Effective Localization in Tumor-Induced Osteomalacia Using 68Ga-Dotatoc-Pet/Ct, Venous Sampling and 3t-Mri
Endocrinology, Diabetes and Metabolism Case Reports
Internal Medicine
Endocrinology
Metabolism
Diabetes
Tumor-Induced Osteomalacia; A Case Report.
Orthopedics & Traumatology
The Promotion of Plasmacytoma Tumor Growth by Mesenchymal Stroma Is Antagonized by Basic Fibroblast Growth Factor Induced Activin A
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Fibroblast Growth Factor Receptor 4 Regulates Tumor Invasion by Coupling Fibroblast Growth Factor Signaling to Extracellular Matrix Degradation
Cancer Research
Cancer Research
Oncology
Fibroblast Growth Factor 23 Weakens Chemotaxis of Human Blood Neutrophils in Microfluidic Devices
Scientific Reports
Multidisciplinary
Nonremission and Recurrent Tumor‐induced Osteomalacia: A Retrospective Study
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Multiple Faces of Fibroblast Growth Factor-23
Current Opinion in Nephrology and Hypertension
Internal Medicine
Nephrology